The present disclosure relates generally to a sensing device used with a surgical diagnostic system for detecting artificially induced neuromuscular activity.
Traditional surgical practices emphasize the importance of recognizing or verifying the location of nerves to avoid injuring them. Advances in surgical techniques include development of techniques including ever smaller exposures, such as minimally invasive surgical procedures, and the insertion of ever more complex medical devices. With these advances in surgical techniques, there is a corresponding need for improvements in methods of detecting and/or avoiding nerves.
In many surgical procedures, it may be common to include ancillary monitoring devices or therapeutic devices provided around limbs or other anatomy of the subject. Examples may include anti-embolism stockings, sequential compression devices, blood pressure cuffs, anesthesia monitoring devices, and the like. When used, these devices may cover portions of the body and limit access to muscles that may otherwise need to be monitored for the purpose of active nerve detection.
A neural monitoring system, including a sleeve-like neuromuscular sensing device is provided to detect an artificially-induced mechanical response of a muscle to stimulus provided within an intracorporeal treatment area of a human subject. The intracorporeal treatment area generally includes a nerve that innervates one or more monitored muscles, which are in direct communication with the sensing device.
In an embodiment, the sensing device may include a carrier material and a plurality of mechanical sensors. The carrier material is operative to be secured around a portion of the limb, and each of the plurality of mechanical sensors are coupled with the carrier material. Each mechanical sensor is positioned on the carrier material such that it is operative to monitor a mechanical response of a different muscle group of the limb. Each mechanical sensor then generates a respective mechanomyography output signal corresponding to the monitored mechanical response of its adjacent muscle group. These signals may then be communicated outbound from the device via communication circuitry provided on the device.
The features and advantages and other features and advantages of the present technology are readily apparent from the following detailed description when taken in connection with the accompanying drawings.
“A,” “an,” “the,” “at least one,” and “one or more” are used interchangeably to indicate that at least one of the item is present; a plurality of such items may be present unless the context clearly indicates otherwise. All numerical values of parameters (e.g., of quantities or conditions) in this specification, including the appended claims, are to be understood as being modified in all instances by the term “about” whether or not “about” actually appears before the numerical value. “About” indicates that the stated numerical value allows some slight imprecision (with some approach to exactness in the value; about or reasonably close to the value; nearly). If the imprecision provided by “about” is not otherwise understood in the art with this ordinary meaning, then “about” as used herein indicates at least variations that may arise from ordinary methods of measuring and using such parameters. In addition, disclosure of ranges includes disclosure of all values and further divided ranges within the entire range. Each value within a range and the endpoints of a range are hereby all disclosed as separate embodiment.
The present disclosure provides a sensing device for detecting an artificially induced neuromuscular response of a subject. The device may include an array of neuromuscular sensors that are provided on a carrier material, which is operative to be secured to or around a portion of a limb of the subject. The sensor array may monitor a plurality of muscle groups of the limb, for example, by positioning one or more sensors into contact with the skin of the subject immediately adjacent to the respective muscle group. In most embodiments, each sensor in the array includes a mechanical sensor that is operative to monitor the mechanical motion of the adjacent muscle group. Using various processing techniques, the system may be capable of discerning whether the sensed mechanical motion is representative of an artificially induced muscle response, such as may be caused by an electrical stimulus provided to an innervating nerve. These processing techniques may involve actively filtering out noise, gross motion, and/or signal content outside of an expected response window, while also examining the signal or signals from the sensors for attributes or patterns that are indicative of an induced response. If the processing and event detection is performed locally on the device, then in some embodiments, the sensor device may be capable of transmitting, via the communications circuitry, one or more analog signal traces that are representative of the induced muscle response.
To minimize pre-operative setup while reducing the potential for error, the sensor device may be provided as an integrated unit that may be affixed to the subject by either securing it around the limb (similar to a blood pressure cuff) or by pulling the device onto the subject, such as with anti-embolism stockings. In doing so, the carrier material may locate the array about the subject in a quicker manner than if each sensor was individually placed.
In some embodiments, the sensor device may include onboard processing capabilities and onboard communication circuitry that is operative to transmit one or more alerts or mechanomyography output signals to a host system that is in digital communication with the device. The sensor device may further incorporate ancillary functionality, which eliminates the need for any sensing or therapeutic systems that would otherwise compete with the neuromuscular sensors for space on the subject. Providing an integrated sensing device in this manner minimizes any required pre-operative setup (i.e., one properly located device may serve multiple purposes). Examples of such ancillary functionality may include anesthesia monitoring functionality, thromboembolism-deterrent functionality, blood pressure monitoring functionality, biometric and/or vital monitoring, and the like.
To reduce the potential for improper affixment/positioning on the subject, in some embodiments, the system and/or sensing device may be capable of performing one or more diagnostic routines that investigate whether the device is positioned in the correct orientation about the limb, and whether it is positioned on the correct limb at all. If the device is not properly oriented or positioned on the body, the sensing device may provide an alert, which may inform a surgeon to a potential loss of accuracy in the monitored parameters. In some embodiments, the use of an array of sensors across the limb may provide additional gross motion rejection by more easily identifying a gross translation or rotation of the limb (i.e., if all sensors move in unison, then the sensed motion is not likely induced by the electrical depolarization of a nerve). While it is noted above that ancillary functionality may be included into the sensor device, in some embodiments, the ancillary functionality may rely on the neuromuscular sensors provided in the array to serve a dual purpose and enable the ancillary functionality. An example of this may include depth of anesthesia monitoring, where a Train of Four (ToF) stimulus may be provided to the limb, while the sensors monitor for the response to the ToF stimulus. Similarly, Nerve Conduction Velocity measurements may be performed, in part by examining when different muscle group contractions occur (via the sensor array) in response to a single stimulus.
Referring to the drawings, wherein like reference numerals are used to identify like or identical components in the various views,
As used herein, an “artificially induced neuromuscular response” is a response of a muscle to a depolarizing stimulus that is applied to a nerve innervating the muscle. In general, the response is “artificially induced” because the nerve is depolarized directly by the stimulus, instead of, for example, the stimulus being received through an intermediate sensory means (e.g., sight, sound, taste, smell, and touch). An example of a stimulus that may cause an “artificially-induced” muscle response may include an electrical current applied directly to the nerve or to intracorporeal tissue or fluid immediately surrounding the nerve. In such an example, if the applied electrical current is sufficiently strong and/or sufficiently close to the nerve, it may artificially cause the nerve to depolarize (resulting in a corresponding contraction of the muscle or muscles innervated by that nerve). Other examples of such “artificial stimuli” may involve mechanically-induced depolarization (e.g., physically stretching or compressing a nerve, such as with a tissue retractor), thermally-induced depolarization (e.g., through ultrasonic cautery), or chemically-induced depolarization (e.g., through the application of a chemical agent to the tissue surrounding the nerve).
During an artificially induced neuromuscular response, a muscle innervated by the artificially depolarized nerve may physically contract or relax (i.e., a mechanical response) and/or the electrical potential throughout the muscle may be altered. Mechanical responses may primarily occur along a longitudinal direction of the muscle (i.e., a direction aligned with the constituent fibers of the muscle), though may further result in a respective swelling/relaxing of the muscle in a lateral direction (which may be substantially normal to the skin for most skeletal muscles). This local movement of the muscle during an artificially-induced mechanical muscle response may be measured relative to the position of the muscle when in a non-stimulated state.
The neural monitoring system 10 may generally include a host system 20 and a sensing device 30 that may cooperate to detect a neuromuscular response of a muscle to a stimulus 42 provided by a stimulator 40. As schematically shown in
In general, the one or more input devices 22 may include a keyboard, a mouse, and/or a digitizer provided with a touch-screen display. These devices may receive pre-operative case information or may permit a surgeon to alter various intraoperative parameters, alarm limits, or other case information before or during a procedure. In some embodiments, the stimulator 40 and/or a foot pedal 44 may provide additional input to the host system 20. This input may be in the form of an analog or digital signal that is indicative of the delivery and/or magnitude of a stimulus. The output device 24 may include, for example, a visual display such as an LED/LCD display, one or more indicator lights, or speakers capable of providing an audible alert to the surgeon.
The sensing device 30 is the portion of the system 10 that directly contacts the subject 14 and is responsible for, at a minimum, sensing/detecting neuromuscular responses of the subject 14. The sensing device 30 includes a carrier material 32 that is operative to be secured to the subject 14, and a plurality of neuromuscular sensors 34 that are coupled with the carrier material 32 and each operative to monitor a neuromuscular response of a different muscle group of the subject 14. The sensing device 30 may further include communication circuitry 36 that is operative to digitally communicate with the communication circuitry 26 of the host system 20, and a local processor 38 that is in communication with the plurality of neuromuscular sensors 34 and with the communication circuitry 36. In general, processors used with the present system 10 (e.g., processors 28, 38) may each be embodied as one or multiple digital computers, data processing devices, and/or digital signal processors (DSPs), which may have one or more microcontrollers or central processing units (CPUs), read only memory (ROM), random access memory (RAM), electrically-erasable programmable read only memory (EEPROM), a high-speed clock, analog-to-digital (A/D) circuitry, digital-to-analog (D/A) circuitry, input/output (I/O) circuitry, and/or signal conditioning and buffering electronics.
While the specific nature of the sensing device 30 and carrier material 32 may vary based on the location of the surgical site and nature of the surgical procedure, in many cases the carrier material 32 may resemble a cuff or sleeve that is secured around a limb of the subject. Such a design may be suitable, for example, with a spinal procedure where nerves existing within the surgical site are known to innervate peripheral muscles of the arms or legs.
In some embodiments, the carrier material 32 may be a separate therapeutic or diagnostic device that is already common in surgical applications. For example, in a spinal procedure involving one or more of the L2-S1 vertebrae, it is known that nerve roots innervating the leg muscles may lie within the surgical area. During such procedures, however, compression-type anti-embolism stockings (Thrombo-Embolic-Deterrent (“TED”) hose) are typically provided around a subject's legs and feet to discourage blood clot formation. Thus, in one embodiment the carrier material 32 may be an elastic sleeve/stocking configured to apply a compressive force to the subject's leg when worn, thus eliminating the need for separate TED hose. Such a compression against the subject may present itself as an elastic tension/strain in the carrier material itself (also referred to as a “tension fit”). In surgical procedures performed higher on the spine, the carrier material 32 may include, for example, a blood pressure cuff worn around the subject's arm (or else may include functionality similar to that of a standard blood pressure cuff). In these examples, the carrier material 32 serves a function outside of that of a dedicated neuromuscular sensing device, and thus provides efficiencies in pre-op preparation and planning, while also allowing monitoring access on sometimes crowded limbs.
From the perspective of the sensing device 30, the carrier material's main purpose is to hold the neuromuscular sensors 34 in relatively stable contact with the skin of the subject. While the present technology has a beneficial use with electromyography (EMG) (i.e., by ensuring that needle electrodes are held in firm, relative position in the muscle without much risk of falling out), the full functionality of the device 30 is best realized when the neuromuscular sensors 34 are configured to monitor the mechanical responses of the various muscles, or, at a minimum, capable of detecting the static force of gravity. Therefore, while in one embodiment, the neuromuscular sensors 34 are or include EMG electrodes, in a more preferred embodiment, the neuromuscular sensors 34 each include a respective mechanical sensor 50 (such as shown in
In various embodiments, the mechanical sensor 50 in each neuromuscular sensor 34 may include, for example, a strain gauge, a pressure/force transducer, a position encoder, an accelerometer, a piezoelectric material, or any other transducer or combination of transducers that may convert a physical motion into a variable electrical signal. As will be discussed below, in particular embodiments, the inclusion of an accelerometer or other sensor capable of measuring the direction of a gravitational force may enable diagnostics that may not be possible with other sensors such as electrodes, strain gauges, or pressure mapping meshes/films (e.g., sensors that operate on the basis of monitoring electrical potentials, contact pressures, tensions, or local flexure). In some embodiments where a pressure, tension, or flexure-based mechanical sensor is most appropriate for monitoring the neuromuscular response, an accelerometer may still be included for ancillary diagnostic purposes.
As noted above, the system 10 may further include one or more elongate medical instruments 40 (i.e., stimulators 40) that are capable of selectively providing a stimulus 42 within the intracorporeal treatment area 12 of the subject 14. For example, in one configuration, the elongate medical instrument 40 may include a probe 46 (e.g., a ball-tip probe, k-wire, or needle) that has an electrode 48 disposed on a distal end portion. The electrode 48 may be selectively electrified, at either the request of a user/physician, or at the command of the processor 28, to provide an electrical stimulus 42 to intracorporeal tissue of the subject. In other configurations, the elongate medical instrument 40 may include a dilator, retractor, clip, cautery probe, pedicle screw, or any other medical instrument that may be used in an invasive medical procedure. Regardless of the instrument, if the intended artificial stimulus is an electrical current, the instrument 40 may include a selectively electrifiable electrode 48 disposed at a portion of the instrument that is intended to contact tissue within the intracorporeal treatment area 12 during the procedure.
During a surgical procedure, the user/surgeon may selectively administer the stimulus to intracorporeal tissue within the treatment area 12 to identify the presence of one or more nerve bundles or fibers. For an electrical stimulus 42, the user/surgeon may administer the stimulus, for example, upon depressing a button or foot pedal 44 that is in communication with the host system 20. The electrical stimulus 42 may, for example, be a periodic stimulus that includes a plurality of sequential discrete pulses (e.g., a step pulse) provided at a frequency of less than about 10 Hz, or from about 1 Hz to about 5 Hz, and preferably between about 2 Hz and about 4 Hz. Each pulse may have a pulse width within the range of about 50 μs to about 400 μs. In other examples, the discrete pulse may have a pulse width within the range of about 50 μs to about 200 μs, or within the range of about 75 μs to about 125 μs. Additionally, in some embodiments, the current amplitude of each pulse may be independently controllable.
If a nerve extends within a predetermined distance of the electrode 48, the electrical stimulus 42 may cause the nerve to depolarize, resulting in a mechanical twitch of a muscle that is innervated by the nerve (i.e., an artificially-induced mechanical muscle response). In general, the magnitude of the response/twitch may be directly correlated to the distance between the electrode and the nerve, the impedance between the electrical stimulus and the ground patch, and the magnitude of the stimulus current. In one configuration, a lookup table may be employed by the processor 28 to provide an approximate distance between the electrode and the nerve, given a known stimulus magnitude and a measured mechanical muscle response.
As noted above, each mechanical sensor 50 may be specially configured to monitor a local mechanical movement of an adjacent muscle group of the subject 14. In response to this sensed movement, each respective mechanical sensor 50 may generate a mechanomyography (MMG) output signal 52 that corresponds to the sensed mechanical movement, force, and/or response of the adjacent muscle. The MMG output signal 52 may be either a digital or analog signal, and the sensor 50 may further include any communication circuitry or local processing circuitry 54 that may be required to transmit the MMG output signal 52 (or a suitable representation thereof) to the processor 38 via a wired or wireless communications. In some embodiments, the sensor 34 may further include a local alert capability, such as a lighting module 56 or audible alert module that may operate at the direction of the local processing circuitry 54 or local processor 38.
The communications circuitry 36 of the sensing device 30 may digitally communicate with the communications circuitry 26 of the host system 20 through any suitable wired or wireless communications means. The respective circuitry 26, 36 may permit unidirectional or bidirectional communications, and may be chosen, in part, according to the number of sensing devices 30 are concurrently used during a procedure (noting that many Bluetooth protocols require point-to-point pairing). Suitable wired protocols include I2C, CAN, TCP/IP, while suitable wireless protocols include IEEE 802.11, Bluetooth, ZigBee, NFC, RFiD or the like.
The following description of setup and operation of the sensing device 30 will be made with respect to a lumbar spinal procedure where the sensing device 30 is provided on a leg of the subject 14. It should be appreciated that the specific nature procedure is illustrative, and should not be read as limiting. The following principles of operation can similarly apply to other procedures, such as spinal procedures performed on the cervical spine (e.g., C5-T1—with the sensing device provided on an arm of the subject), or with other such procedures.
To assist the medical staff in achieving proper alignment of the sleeve on the leg of the subject, the carrier material 32 may include one or more alignment indicia 68 from which relative orientation may be quickly identified. These indicia 68 may include, anatomical markers, such as indications or holes for a knee cap or ankle bone, marks to align with other equipment, marks to align with anatomical reference planes or the like. In one embodiment, the indicia 68 may include a line that extends along a majority of the length of the stocking/sleeve, and/or at certain anatomical waypoints along the length of the limb, such as shown in
In some embodiments, the processor 38 may be configured to use one or more of the mechanical sensors 50 to determine if the sensing device 30 is placed on the correct limb for the given procedure and/or is placed in the proper orientation relative to that limb. In a general sense, this limb/orientation detection functionality relies on an understanding of the nature of the procedure together with an understanding of the static force of gravity acting on the sensor 50.
As shown in
During this initial setup phase, the sensing device 30 may also be secured around a portion of the limb of the subject 14 (at 74). In this step, it is preferable for the neuromuscular sensors 34/mechanical sensors 50 to each be positioned in contact with or immediately adjacent to the skin above a different muscle group. In doing so, should there be a movement/response of the underlying muscle group, the adjacent sensor 50 would also experience and detect that motion. During this process, any provided alignment indicia 68 should be used to aid in properly orienting the device 30 about the limb.
Each of the plurality of sensors 50 may be energized at 76, after which they may begin generating one or more MMG output signals 52 corresponding to any sensed movement or forces. This step may involve, for example, plugging the sensing device into a power source, flipping a switch (physical or in software), or pulling a barrier tab out of a battery compartment.
Once energized and in place, the processor 38 may then perform one or both of an orientation diagnostic algorithm 78 and/or a limb verification algorithm 80 to ensure that the device 30 is properly positioned and capable of monitoring induced muscle responses should they occur. In a general sense, the orientation diagnostic algorithm 78 may be operative to alert the surgical team if the sensing device might be improperly oriented relative to the subject 14. Likewise, the limb verification algorithm 80 may alert the surgical team if there is a possibility that the sensing device 30 might be positioned on an opposite side of the subject's body from what is intended. Each determination may generally depend on the direction of the force of gravity 100 (shown in
The orientation diagnostic algorithm 78 may begin at 82 by determining the actual orientation of the sensing device 30 about the limb. As schematically shown in
As may be appreciated, the MMG output signal 52 may represent the resultant gravity vector 100 as the sum of static forces sensed in multiple orthogonal axes. Calculations may be simplified by orienting the sensing axes such that a first axis is normal to the skin, the second is parallel to a longitudinal axis of the limb, and the last is tangent to a circumference of the limb. In performing the orientation determination, the processor 38 may omit any static gravity component measured in the axis parallel to the longitudinal axis of the limb/sleeve. Doing so would focus the orientation analysis on relative rotation of the sensing device 30 about the limb, and not on limb elevation, which is less relevant for device orientation purposes.
Referring again to
If the current orientation of the sensing device 30 does not match the intended orientation (within an acceptable tolerance), an alert may be provided (at 86). The alert at 86 may include, for example, a visual or audible alert provided via the output device 24 of the host system 20, or, in some embodiments, may include a light or sound provided directly from the sensing device 30 to indicate misalignment. For example, in one embodiment, the lighting module 56 provided on each sensor 34 (such as shown in
Referring again to
As shown in
The processor 38 may then compare this determined sensor orientation with an expected sensor orientation (at 90) to determine whether the sensing device is likely on the correct limb. This comparison may entail one or both of: determining if the sensor orientation is within a predefined angular tolerance of an expected orientation; or estimating both the orientation of the sensor if positioned on the correct limb and if positioned on the incorrect limb, and then determining whether the actual orientation is closer to one or the other. In some embodiments, the expected sensor orientations (for both algorithms 78, 80) may account for variations in the weight of the subject (e.g., via body mass index values) and/or for variations in the actual circumference of the subject's limbs.
If the determined sensor orientation is outside of a predetermined tolerance of the expected heading and/or if it more closely resembles the orientation on the incorrect limb than the correct limb, the processor 38 may provide an alert (at 92) to call attention to the potentially incorrect positioning. Similar to the orientation alert provided at 86, a limb placement alert may be provided by the host system 20, or by one or more lights or speakers associated with the sensing device 30.
In general, the orientation detection algorithm 78 may be most useful for compression sleeves that are generally radially symmetric and/or that do not have provisions for a subject's foot. Limb verification is useful regardless of the symmetry of the device, though it is preferable (though not strictly necessary) for the limb verification algorithms 80 to be performed once the device is properly oriented.
Once the sensing devices are properly positioned on the subject 14, the system 10 may generally operate by applying a stimulus 42 to an intracorporeal treatment are 12 of the subject 14 via the stimulator 40, and then monitoring the resulting neuromuscular activity to determine the existence of an artificially induced muscle response. Because the key to much of the nerve detection lies in the sensing of muscular responses, it may be beneficial for the system 10 to first understand what type and/or magnitude of a response the muscle may be capable of producing prior to beginning the procedure. Understanding a subject's specific response profile may be particularly useful with subjects that have a history of diabetes or neurodegenerative conditions, that have excess subcutaneous fat which may dampen a response or otherwise complicate accurate sensor placement, or that have a general lack of muscle tone/conditioning. In some embodiments, the results from these pre-op muscle diagnostics may be used to scale future responses as a percentage of a maximum possible response, understand approximately the minimum stimulus needed to evoke a response, and/or understand how the magnitude of a muscle response may vary as a function of an applied stimulus.
To perform the pre-op muscle diagnostics, the sensing device 30 may include at least a pair of transdermal surface electrodes 120 (shown in
In a variation of this method 122, the processor 38 may provide a plurality of submaximal electrical stimuli over a period of time, with each submaximal stimulus having a different current magnitude. By monitoring the response to each submaximal stimulus, the processor 38 may then develop a response sensitivity curve that reflects muscle response as a function of transdermal stimulus current. While the numeric relationship between transdermal current and response magnitude may not be directly applicable for stimuli provided within the body (i.e., unless the impedance of the skin was measured prior to testing), the shape of the sensitivity curve may be relevant and used to scale the system's pre-existing understanding of the relationship between stimulus magnitude, response magnitude, and distance between a stimulus and a nerve (i.e., the shape of the response curve may be used to adjust the decay rate of the intraoperative relationships to achieve a better fit given the subject's own neuromuscular anatomy).
Following the receipt of the fourth response, the processor 38 may compute a Train of Four ratio (at 138). The Train of Four ratio is computed as the ratio of the amplitude of the MMG output signal 52 in response to the fourth administered electrical stimulus to the amplitude of the MMG output signal 52 in response to the first administered electrical stimulus. The processor 38 may then compare this determined Train of Four ratio to a pre-determined threshold (at 140), and may provide an alert to the user (at 142) if the ratio is below the pre-determined threshold. Similar to the orientation and limb alerts discussed above, the nerve block alert may be provided by the host system 20, or by one or more lights or speakers associated with the sensing device 30.
It should be appreciated that, while the Train of Four analysis is well known in the field of anesthesia monitoring, the present system 10 both integrates this functionality/diagnostic into the existing sensor device 30 (i.e., improved efficiency of setup and sensor positioning) and uses the output to inform the surgeon whether there is an anesthetic that could negatively affect the performance or reliability of the system 10. Incorporation of this functionality eliminates the need for a secondary monitoring system, and uses the results of the test for a purpose outside the field of anesthesiology. Furthermore, incorporation of Train of Four diagnostics leverages the existing sensors 34 to minimize the need for redundant sensing.
In situations where the neuromuscular sensor 34 is or includes a mechanical sensor 50, the artificially induced muscle responses may occur against a background of potentially unrelated limb motion, such as procedure related motion, inadvertent bumps into the operating table, or other such environmental or intentional mechanical noise. Therefore, to properly analyze the MMG output signals 52 and determine the occurrence and magnitude of the induced muscle response, it may be desirable to filter the MMG output signals 52 to remove or attenuate signal content that is indicative of a gross translation or rotation of the limb.
In one embodiment, the sensing device 30 may detect gross translations or rotations by virtue of having a plurality of mechanical sensors 50 held in varying positions around the limb by the carrier material 32. More specifically, if each of the plurality of sensors 50 output a respective signal 52 that, when viewed collectively suggests a coordinated translation or rotation (i.e., a global motion rather than a local motion), any signal content specific to that global motion can be digitally removed. To accomplish this motion detection, in one embodiment, each sensor 50 may directly plug into a local processor 38 that may coordinate the received signals in time (e.g., through the use of time-stamps, clock synchronization, or other buffering or signal processing techniques). The processor 38 may then examine the collection of MMG output signals to identify any motion that is common between the sensors or that is otherwise indicative of a gross translation or rotation of the limb. If any such motion is identified, it may be filtered, attenuated, or otherwise removed from each respective output signal 52 prior to the system performing any further analysis.
In some embodiments, the processor 38 may perform this gross motion rejection by mapping each sensor reading to a three dimensional (virtual) solid model of the limb. This mapping may be accomplished by understanding the number and relative placement of the sensors on the device 30, and by mapping the actual sensed motion to corresponding points on a virtual solid model of the limb. In some embodiments, the processor 38 may receive an indication of the subject's anatomy (e.g., body mass index (BMI), limb circumference, or percent body fat) to scale the size and presumed elastic modulus of the virtual solid model. The global motion may then be extracted from the model, for example, by examining the motion of, for example, the centroid of the model or of a rigid body diagram/representation of the limb.
In some embodiments, using a virtual limb model may not only enable gross motion detection by inspecting the motion of the model, itself, but it may also permit virtual sensor points to be dropped on the model, which may provide a more complete/higher resolution picture of how the limb is responding/moving. This better understanding of the limb motion may then enable greater accuracy when detecting the occurrence and magnitude of an artificially neuromuscular response, while serving to reduce the overall noise floor of the system.
In some embodiments, the system 10 may be configured to automatically perform one or more signal processing algorithms or methods (i.e., via processor 28 and/or 38) to determine whether a mechanical movement sensed by the sensing device 30 is representative of an artificially-induced mechanical muscle response or if it is merely a subject-intended muscle movement and/or an environmentally caused movement. These processing algorithms may be embodied as software or firmware, and may either be stored locally on the processor 28, 38, or may be readily assessable by the processor 28, 38.
The offset 204 between T1 and T3, if one were to exist would be minimal, as the delay between stimulation and the initial muscle response 190 is only limited by the speed at which the nerve signal propagates, the length of the nerve, and the dynamics of the muscle to actually contract in response to the nerve signal. In most patients, motor nerves can conduct generally between about 40 m/s and about 80 m/s, which could result in about a 5-20 ms delay until the start of the muscular contraction. In some embodiments, the start time T3 of the response window 202 could be further refined by accounting for specific attributes of the patient, such as body mass index (BMI), diabetes, neuropathy, degenerative nerve conditions, or other such factors that are known to affect nerve conduction velocity and/or muscular response.
The relative location of T4 within the period 200 may generally be selected such that if a muscle event 188 were to occur in response to the first stimulus 196, a sufficient amount of information related to the event would fall within the response window 202 to properly categorize it as an induced/evoked muscle response. This later bound may generally depend on the amount of time 206 between T1 and the initial onset and/or peak of the muscle response, as well as on the expected duration of the event 188. From a clinical perspective, it is most important that T3 and T4 are selected to capture at least the initial M-wave response 190 within the response window 202. Similar to T3, the offset of T4 relative to T1 may be further refined by accounting for specific attributes of the patient, such as body mass index (BMI), diabetes, neuropathy, degenerative nerve conditions, muscle fatigue, or other such factors that are known to affect nerve conduction velocity and/or muscular response.
Properly sizing the response window 202 within the period 200 between the stimuli may enable the processor to summarily reject some muscle events (or other detected movements) if those events occur outside of the expected response window 202. Such an analysis may be performed separately for each sensor/sensor channel as a threshold inquiry into whether signal content is representative of a stimulus-induced response. As an example, if a periodic stimulus was applied to a subject at a frequency of 2 Hz (500 ms period), any given pulse may be expected to elicit a response within about the first 100 ms of the onset of the pulse (i.e., with slight variability based on the health of the patient). If a purported muscle event 188 was detected in the later 400 ms of the period 200, it may be safe to assume that the applied stimulus did not cause that motion.
Using these assumptions, in one embodiment, the processor may be configured to only perform the signal processing algorithms on sensed motion or candidate muscle events (i.e., muscle responses that either exceed a certain response amplitude threshold, or have some other time or frequency domain characteristic that is indicative of induced responses), that occur within the response window 202. Such a time-gating filter may reduce the total number of candidate events that must be analyzed, which may conserve processing power, improve processing speed, and reduce the potential for false positives. As mentioned above, the response window should be sized such that T1≤T3<T4<T2, however, to best realize the processing improvements, it is preferable for (T4−T3)≤(T2−T1)/2.
In one configuration, the processor may determine the administration of the stimulus (i.e., T1) by either digitally communicating with the stimulator 40 to identify the timing of stimulus 42 (i.e., by digitally directing the stimulator 40 to energize, or by receiving an indication that a stimulus 42 has been administered), or by more directly providing the electrical stimulus energy to the electrode 48. In some embodiments, however, the stimulator 40 may be a standalone device that lacks any direct connection or communication with the sensing device 30. In such an embodiment, the sensing device 30 may still be capable of recognizing the occurrence of the stimulus by monitoring changes in one or more electrical parameters of the subject. More specifically, when an electrical stimulus is applied to the body, the electrical potential of all tissue within the body may momentarily change. When monitored in an electromyography context, such an inrush is generally referred to as a stimulus artifact. While a stimulus artifact is generally viewed as a negative quality (i.e., it can complicate electromyography measurements and potentially obscure changes in the muscle action potential), when used with MMG, the stimulus artifact may provide a near real-time indication that a stimulus has been administered.
Therefore, in one embodiment, such as shown in
In some embodiments, the processor may be configured to perform the signal processing algorithms on sensed motion or candidate muscle events if any one of the plurality of sensors experiences motion or a candidate event within the response window. For example, the MMG output signal on each sensor channel may be recorded in a sliding window/circular buffer until any one channel experiences motion that may be characteristic of a muscular response. At that point, the circular buffer and/or any subsequently received signals for every channel may be stored in an analysis buffer where they may be analyzed individually or collectively to determine whether the candidate motion is representative of an artificially induced response of the muscle.
In some embodiments, the signal processing algorithms used to recognize an induced response may involve one or more analog detection techniques such as described, for example, in U.S. Pat. No. 8,343,065, issued on Jan. 1, 2013 (the '065 patent), which is incorporated by reference in its entirety, and/or one or more digital detection techniques, such as described in US 2015/0051506, filed on Aug. 13, 2013 (the '506 application), which also is incorporated by reference in its entirety. In the analog techniques, the processor may examine one or more aspects of the MMG output signal 52 in an analog/time domain to determine if the sensed response is an artificially-induced response of the muscle to the stimulus. These analog aspects may include, for example, the time derivative of acceleration, or the maximum amplitude of the M-wave/initial response 190.
In a digital context, such as described in the '503 application, the processor may compare the frequency components of the MMG output signal (i.e., in the frequency domain) with the frequency of the applied stimulation to determine whether the sensed muscle responses and/or “events” were induced by the applied stimulus. Such a technique may be made more robust by considering only events or muscle activity that occurs within the reference window 202 and/or by aggressively filtering/attenuating or ignoring the signal outside of the response window 202 prior to applying the signal processing algorithms.
In some embodiments, the signal processing algorithms may include one or more supervised learning algorithms that are operative to classify any sensed motion into one of a plurality of classifications that include at least whether the motion is, or is not representative of an artificially-induced mechanical response of the muscle. Both classifications may provide valuable information to an operating surgeon during a procedure. Affirmatively detecting a response informs the surgeon that a nerve is proximate to the stimulator/tool, and to proceed with caution. Conversely, determining that no induced response occurred, particularly if a stimulus is provided, informs the surgeon that the nerve is not present and they can proceed in their normal manner.
In a general sense, a supervised learning algorithm is an algorithm that attempts to classify a current sample using observations made about prior samples and their known classifications. More specifically, the algorithm attempts to construct and/or optimize a model that is capable of recognizing relationships or patterns between the training inputs and training outputs, and then the algorithm uses that model to predict an output classification given a new sample. Examples of supervised learning algorithms that may be employed include neural networks, support vector machines, logistic regressions, naive Bayes classifiers, decision trees, random forests, or other such techniques or ensembles of techniques.
With continued reference to
In an embodiment, the one or more analog characteristics 218 may include, for example, max/min acceleration amplitudes, max/min velocity amplitudes, time derivative of acceleration, signal rise time, or curve fitting coefficients. Likewise, the one or more frequency characteristics 220 may include, for example, FFT coefficients, peak frequencies, peak frequency magnitudes, harmonic frequencies, or frequency fall-off. Finally, the time-series/image characteristics 222 may include a snapshot of a graph of the MMG output 52 over time (similar to what is shown in
In some embodiments, the supervised learning algorithm 210 may employ an ensemble approach to generating the output classification. In such an approach, the model 224 may include a plurality of different models/approaches that may be combined according to a weighting/costing formula to provide improved redundancy/voting. In another embodiment, the ensemble approach may use the output of one or more approaches/models as an input of another model. For example, the analog and/or frequency based detection techniques discussed in the '065 patent and/or in the '506 application may output a probability or likelihood that an event in question is representative of an induced response. These estimations may then be fed into, for example, a supervised learning algorithm as another input (i.e., where the supervised learning algorithm may understand situations when the pre-determined algorithms are to be trusted or not trusted). In another embodiment, each model, including any supervised learning algorithm may feed into a separate algorithm that may output a binary response or probability based upon the outcomes of the various models. This approach may use voting algorithms, probability combinations, and/or separate supervised learning algorithms to provide an output based on the prediction of each constituent model.
In addition to simply detecting an artificially induced muscle response, in an embodiment, the processor may further be configured to examine the timing between a provided stimulus and a muscle response induced by this stimulus. If this timing changes by more than the threshold amount, the processor 28 may provide an alert to a user to indicate a change in the health of the nerve that innervates the responding muscle. As a general premise, nerve conduction velocity and/or muscle response latency should be faster with a healthy nerve than with an injured or impinged nerve.
Therefore, as generally illustrated in
Once a baseline latency is established, either by computing a single latency, or an average of many successively computed latencies, future latencies (e.g., subsequent latency 268) may be computed in a similar manner and compared to the baseline. More specifically, the processor may be configured to identify a time 270 of a second muscle event 272 within a second response window 274 following a subsequent stimulus 276 provided by the stimulator. The processor may determine the response latency 268 between the stimulus 276 the second muscle event 272, and may then provide an alert if the second response latency 268 differs from the baseline latency by more than a predetermined threshold amount that is set to indicate either a meaningful improvement in the health of the nerve, or a meaningful impairment of the nerve. Additionally, or alternatively, the system 10 may display a constant readout that compares the nerve conduction velocity and/or muscle response latency to either a baseline level measured from that patient, or to a standard or expected velocity/latency, from which changes throughout the procedure can be gauged.
In yet another embodiment, Nerve Conduction Velocity may be computed by monitoring the difference in time between responses in muscle groups innervated by a common nerve root. For example, the L4 nerve root can innervate both the vastus lateralis and the tibialis anterior muscles. As these muscles are separated a distance along the length of the leg, it should be expected that the tibialis anterior muscle should respond with a slight phase delay. By locally processing these signals, it may be possible to detect this delay, and determine the NCV for at least the portion of the nerve between the two muscles, which may provide insight into the overall health of the nervous system (i.e., since it is unlikely for there to be any impingement between these two muscles which may otherwise affect conduction velocity).
In addition to use as a stand alone, or hand-held nerve monitoring apparatus, the present nerve monitoring system 10 and described artificially-induced mechanical muscle response detection algorithms (as described within method 210) may be used by a robotic surgical system, such as described in U.S. Pat. No. 8,855,622, issued Oct. 7, 2014 entitled “ROBOTIC SURGICAL SYSTEM WITH MECHANOMYOGRAPHY FEEDBACK,” which is incorporated by reference in its entirety and for all of the disclosure set forth therein. In such a system, the above-described neural monitoring system 10 may be used to provide one or more control signals to a robotic surgical system if an artificially-induced mechanical muscle response is detected. In such an embodiment, the one or more elongate medical instruments 46 described above may be robotically controlled in up to 6 or more degrees of freedom/motion by a robotic controller. This instrument may be configured to perform a surgical procedure within an intracorporeal treatment area at the direction of the robotic controller, and may provide an electrical stimulus 42 in the manner described above. If an artificially-induced mechanical muscle response is detected, the neural monitoring system 10 may instruct the robotic controller (via the provided control signal) to limit the range of available motion of the elongate medical instrument 46 and/or to prevent an actuation of an end effector that may be disposed on the instrument 46 and controllable by the robotic controller.
While the best modes for carrying out the present technology have been described in detail, those familiar with the art to which this technology relates will recognize various alternative designs and embodiments that are within the scope of the appended claims. It is intended that all matter contained in the above description or shown in the accompanying drawings shall be interpreted as illustrative only and not as limiting.
Various advantages and features of the disclosure are further set forth in the following clauses:
Clause 1: A sensing device for detecting an artificially induced neuromuscular response within a limb of a subject, the sensing device comprising: a carrier material operative to be secured around a portion of the limb; a plurality of mechanical sensors coupled with the carrier material, each mechanical sensor positioned on the carrier material such that it is operative to monitor a mechanical response of a different muscle group of the limb, and wherein each mechanical sensor generates a respective mechanomyography output signal corresponding to the monitored mechanical response, and from which an artificially induced neuromuscular response within the limb can be detected; and communication circuitry coupled with the carrier material and in electronic communication with each of the plurality of mechanical sensors, the communication circuitry operative to transmit one or more of the generated mechanomyography output signals to a host system.
Clause 2: The sensing device of clause 1, wherein the carrier material is a sleeve operative to maintain an elastic tension fit about the limb of the subject.
Clause 3: The sensing device of clause 2, wherein the plurality of mechanical sensors includes a first sensor positioned on the carrier material such that it is directly adjacent to and operative to monitor a mechanical response of at least one the vastus medialis muscle or the vastus lateralis muscle when the carrier material is secured around a portion of the limb in a proper orientation; and wherein the plurality of mechanical sensors includes a second sensor positioned on the carrier material such that it is directly adjacent to and operative to monitor a mechanical response of the tibialis anterior muscle when the carrier material is secured around the portion of the limb in the proper orientation.
Clause 4: The sensing device of any of clauses 1-3 further comprising a processor in communication with the plurality of mechanical sensors.
Clause 5: The sensing device of clause 4, wherein the processor is configured to: receive an indication of the nature of a procedure to be performed on the subject, the nature of the procedure being indicative of a side of the subject's body where the procedure will be performed; receive at least one mechanomyography output signal; identify whether the limb is a right limb or a left limb from a static component of the received mechanomyography output signal; and provide an alert if the limb is not on the side of the subject's body where the procedure will be performed.
Clause 6: The sensing device of any of clauses 4-5, wherein the processor is configured to: receive an indication of an intended posture of the subject during a procedure to be performed on the subject, the intended posture of the subject being indicative of a proper orientation of the sleeve during the procedure; receive at least one mechanomyography output signal; determine an actual orientation of the sleeve from a static component of the at least one mechanomyography output signal; and provide an alert if the actual orientation of the sleeve does not match the proper orientation of the sleeve.
Clause 7: The sensing device of any of clauses 4-6, wherein the processor is in communication with and between the plurality of mechanical sensors and the communication circuitry; and the processor configured to filter each of the mechanomyography output signals to remove signal content that is indicative of a gross translation or rotation of the limb.
Clause 8: The sensing device of clause 7, wherein the processor is configured to identify signal content that is indicative of a gross translation or rotation of the limb by mapping the sensed motion from each of the plurality of sensors to a virtual limb, and determining whether there is a translation or rotation of the virtual limb.
Clause 9: The sensing device of any of clauses 4-8, wherein the processor is configured to: receive an indication that a stimulus has been administered within an intracorporeal treatment area of the subject apart from the limb; analyze each of the mechanomyography output signals to determine whether the stimulus induced a mechanical, neuromuscular response of one or more of the muscle groups within the limb of the subject; and provide an alert if it is determined that the stimulus induced the neuromuscular response.
Clause 10: The sensing device of clause 9, wherein the processor is configured to only analyze each of the mechanomyography output signals within a response window following the administration of the stimulus.
Clause 11: The sensing device of any of clauses 9-10, wherein the processor is configured to determine whether the stimulus induced the mechanical, neuromuscular response of one or more of the muscle groups within the limb of the subject by examining one or more characteristics of one or more received mechanomyography output signals using a supervised learning algorithm; and wherein the supervised learning algorithm is operative to classify the response window into one of a plurality of classifications comprising: the response window is representative of an induced neuromuscular response; and the response window is not representative of an induced neuromuscular response.
Clause 12: The sensing device of any of clauses 9-11, wherein the processor is local to the sensing device and attached to the carrier material; and wherein the communication circuitry is operative to transmit one or more of the generated mechanomyography output signals to the host system only if it is determined that the stimulus induced the neuromuscular response.
Clause 13: The sensing device of any of clauses 9-12, wherein the processor is further configured to determine a nerve conduction velocity by either computing the time delay between the stimulus and a muscle response induced by the stimulus, or by computing the time delay between muscle responses from different muscle groups innervated by a common nerve.
Clause 14: The sensing device of any of clauses 1-13, further comprising: a pair of surface electrodes coupled with the carrier material such that they are operative to directly contact a skin surface of the subject when the carrier material is secured around the portion of the limb; and a processor in electrical communication with the pair of surface electrodes, the processor configured to administer an electrical stimulus directly to the limb via the electrodes.
Clause 15: The sensing device of clause 14, wherein the stimulus is a Train of Four electrical stimulus that includes four discrete electrical pulses; the processor further configured to: monitor the mechanomyography output signal from one of the plurality of mechanical sensors for a mechanical response to each of the four discrete electrical pulses of the Train of Four electrical stimulus; compute a Train of Four ratio from the monitored mechanomyography output signal, the Train of Four ratio being a ratio of an amplitude of the mechanomyography output signal in response to the fourth of the four discrete electrical pulses to an amplitude of the mechanomyography output signal in response to the first of the four discrete electrical pulses; and provide an alert indicative of the existence of a neuromuscular block if the Train of Four ratio is below a predetermined threshold.
Clause 16: The sensing device of any of clauses 14-15, wherein the stimulus is a supramaximal stimulus.
Clause 17: The sensing device of clause 16, wherein the processor is operative to: receive a mechanomyography output signal representative of the mechanical response of a muscle in response to the administered supramaximal stimulus; and scale one or more of the mechanomyography output signals as a function of a magnitude of the mechanical response of the muscle in response to the administered supramaximal stimulus.
Clause 18: The sensing device of any of clauses 1-17, wherein the carrier material is an anti-embolism stocking.
Clause 19: The sensing device of clause 18, wherein the anti-embolism stocking includes one or more alignment indicia to indicate the proper orientation of the stocking relative to the limb.
Clause 20: The sensing device of clause 19, wherein the alignment indicia is a line extending along a majority of the length of the stocking, the line operative to indicate twisting of the stocking when worn by the subject.
Clause 21: The sensing device of any of clauses 1-20, wherein the communication circuitry is wireless digital communications circuitry; and wherein the wireless digital communications circuitry is operative to transmit the one or more generated mechanomyography output signals to the host system via a wireless communications protocol.
Clause 22: A sensing device for detecting an artificially induced neuromuscular response within a limb of a subject, the sensing device comprising: a sensor array comprising a plurality of mechanical sensors, each sensor operative to monitor a mechanical response of a different muscle group of the limb and generate an output signal corresponding to the monitored response; and a processor in communication with the sensor array, the processor configured to receive the output signal from each sensor in the sensor array and to determine if any one or more output signal is indicative of an artificially induced neuromuscular response.
Clause 23: The sensing device of clause 22, further comprising a carrier material operative to be secured around a portion of the limb, and wherein each sensor in the sensor array is coupled with the carrier material.
Clause 24: The sensing device of clause 23, wherein the carrier material is operative to maintain an elastic tension fit about the limb of the subject.
Clause 25: The sensing device of any of clauses 23-24, wherein the carrier material is an anti-embolism stocking configured to be secured around a leg of the subject.
Clause 26: The sensing device of any of clauses 23-24, wherein the carrier material is a compression sleeve operative to be secured around an arm of the subject.
Clause 27: The sensing device of clause 26, wherein the compression sleeve further includes a blood pressure cuff/sphygmomanometer.
Clause 28: The sensing device of clause 27, wherein the processor is operative to determine a blood pressure of the subject via selective actuation and/or inflation of the blood pressure cuff together with monitoring of at least one of the sensors in the sensor array.
Clause 29: The sensing device of any of clauses 23-28, further comprising a bipolar transdermal electrical stimulator including at least two electrodes coupled with the carrier material, the electrodes positioned such that each electrode contacts the skin of the subject when the carrier material is secured around the portion of the limb; and wherein the bipolar stimulator is operative to receive and electrically conduct an electrical stimulus from the processor to the subject via the electrodes.
Clause 30: The sensing device of clause 29, wherein the electrical stimulus is a Train of Four electrical stimulus that includes four discrete electrical pulses; the processor further configured to: monitor the output signal from one of the plurality of mechanical sensors for a mechanical response to each of the four discrete electrical pulses of the Train of Four electrical stimulus; compute a Train of Four ratio from the monitored mechanomyography output signal, the Train of Four ratio being a ratio of an amplitude of the mechanomyography output signal in response to the fourth of the four discrete electrical pulses to an amplitude of the mechanomyography output signal in response to the first of the four discrete electrical pulses; and provide an alert indicative of the existence of a neuromuscular block if the Train of Four ratio is below a predetermined threshold.
Clause 31: The sensing device of any of clauses 29-30, wherein the electrical stimulus is a supramaximal stimulus.
Clause 32: The sensing device of clause 31, wherein the processor is operative to: receive a mechanomyography output signal representative of the mechanical response of a muscle in response to the administered supramaximal stimulus; and scale one or more subsequent mechanomyography output signals as a function of a magnitude of the mechanical response of the muscle in response to the administered supramaximal stimulus.
Clause 33: The sensing device of any of clauses 22-32, wherein the processor is configured to: receive an indication of the nature of a procedure to be performed on the subject, the nature of the procedure being indicative of a side of the subject's body where the procedure will be performed; identify whether the limb is a right limb or a left limb from a static component of a received sensor output signal; and provide an alert if the limb is not on the side of the subject's body where the procedure will be performed.
Clause 34: The sensing device of clause 33, wherein the processor is configured to identify whether the limb is a right limb or a left limb from an orientation of the sensor generating the output signal relative to a vector heading of the static component of the output signal, and wherein the static component is indicative of gravity.
Clause 35: The sensing device of clause 34, wherein the sensor generating the output signal is provided on a portion of the limb where the outer skin surface is asymmetric about a bisecting reference plane.
Clause 36: The sensing device of any of clauses 22-35, wherein the processor is configured to: receive an indication of an intended posture of the subject during a procedure to be performed on the subject, the intended posture of the subject being indicative of a proper orientation of the sleeve during the procedure; determine an actual orientation of the sleeve from a static component of the at least one received output signal; and provide an alert if the actual orientation of the sleeve does not match the proper orientation of the sleeve.
Clause 37: The sensing device of clause 36, wherein the static component of the at least one received output signal is indicative of the force of gravity; and wherein the processor is configured to determine the actual orientation of the sleeve relative to the vector heading of the sensed force of gravity.
Clause 38: The sensing device of any of clauses 36-37, wherein the static component of the received output signal only includes a force magnitude in a direction normal to a skin surface of the subject and in a direction tangential to a circumference of the limb.
Clause 39: The sensing device of any of clauses 36-38, wherein the processor is configured to determine the actual orientation of the sleeve by averaging a vector heading of the static component of a plurality of output signals.
Clause 40: The sensing device of any of clauses 33-39, wherein the alert includes at least one of a visual alert and an audible alert.
Clause 41: The sensing device of any of clauses 22-40, wherein the processor is configured to filter each of the output signals to remove signal content that is indicative of a gross translation or rotation of the limb.
Clause 42: The sensing device of clause 41, wherein the processor is configured to: identify signal content that is indicative of a gross translation or rotation of the limb by mapping the sensed motion from each of the plurality of sensors to a virtual limb, and determining whether there is a translation or rotation of the virtual limb.
Clause 43: The sensing device of any of clauses 22-42, wherein the processor is configured to receive an indication that a stimulus has been administered within an intracorporeal treatment area of the subject apart from the limb; analyze each of the output signals to determine whether the stimulus induced a mechanical, neuromuscular response of one or more of the muscle groups within the limb of the subject; and provide an alert if it is determined that the stimulus induced the neuromuscular response.
Clause 44: The sensing device of clause 43, wherein the processor is configured to only analyze each of the output signals within a response window following the administration of the stimulus.
Clause 45: The sensing device of any of clauses 43-44, wherein the processor is configured to analyze each of the output signals within the response window only if one or more of the output signals have a response magnitude that exceeds a threshold within the response window.
Clause 46: The sensing device of any of clauses 43-45, wherein the processor is configured to determine whether the stimulus induced the mechanical, neuromuscular response of one or more of the muscle groups within the limb of the subject by examining one or more characteristics of one or more received output signals using a supervised learning algorithm; and wherein the supervised learning algorithm is operative to classify a sensed motion into one of a plurality of classifications comprising: the sensed motion is representative of an induced neuromuscular response; and the sensed motion is not representative of an induced neuromuscular response.
Clause 47: The sensing device of any of clauses 43-46, wherein the processor is further configured to determine a nerve conduction velocity by either computing the time delay between the stimulus and a muscle response induced by the stimulus, or by computing the time delay between muscle responses from different muscle groups innervated by a common nerve.
Clause 48: The sensing device of any of clauses 22-47, further comprising communications circuitry in communication with the processor; and wherein the communications circuitry is operative to transmit one or more of the output signals to a host system.
Clause 49: The sensing device of clause 48, wherein the communications circuitry is only configured to transmit the one or more output signals to the host system if the processor detects an artificially induced neuromuscular response within the limb of the subject.
Clause 50: A neural monitoring system for detecting an artificially-induced mechanical response of a muscle to a stimulus provided within an intracorporeal treatment area of a human subject, the intracorporeal treatment area including a nerve that innervates the muscle, the neural monitoring system comprising: a host system including a display and a user input; a stimulator configured to provide the stimulus within the intracorporeal treatment area; and the sensing device of any of clauses 1-49.
Clause 51: The neural monitoring system of clause 50, wherein the display is operative to display a trace of one or more of the output signals.
Clause 52: The neural monitoring system of any of clauses 50-51, wherein the host system and sensing device are in wired communication.
Clause 53: The neural monitoring system of any of clauses 50-51, wherein the host system and sensing device are in wireless communication.
Clause 54: The neural monitoring system of any of clauses 50-53, further comprising a second sensing device, the second sensing device according to any of clauses 1-49.
Clause 55: The neural monitoring system of clause 54, where the first sensing device is provided on a first leg of the subject, and wherein the second sensing device is provided on a second leg of the subject.
Clause 56: The neural monitoring system of clause 54, where the first sensing device is provided on a first arm of the subject, and wherein the second sensing device is provided on a second arm of the subject.
The present application is a continuation of U.S. patent application Ser. No. 16/158,734, filed on 12 Oct. 2018, and published as US 2020/0114148, which is incorporated by reference for all that it discloses.
Number | Name | Date | Kind |
---|---|---|---|
3200814 | Taylor et al. | Aug 1965 | A |
3565080 | Ide et al. | Feb 1971 | A |
3797010 | Adler et al. | Mar 1974 | A |
4155353 | Rea et al. | May 1979 | A |
4493327 | Bergelson et al. | Jan 1985 | A |
4807642 | Brown | Feb 1989 | A |
4817628 | Zealear et al. | Apr 1989 | A |
4940453 | Cadwell | Jul 1990 | A |
4994015 | Cadwell | Feb 1991 | A |
5047005 | Cadwell | Sep 1991 | A |
5078674 | Cadwell | Jan 1992 | A |
5116304 | Cadwell | May 1992 | A |
5178145 | Rea | Jan 1993 | A |
5284153 | Raymond et al. | Feb 1994 | A |
5284154 | Raymond et al. | Feb 1994 | A |
5482038 | Ruff | Jan 1996 | A |
5562707 | Prochazka | Oct 1996 | A |
5566678 | Cadwell | Oct 1996 | A |
5593429 | Ruff | Jan 1997 | A |
5631667 | Cadwell | May 1997 | A |
5775331 | Raymond et al. | Jul 1998 | A |
5860939 | Wofford et al. | Jan 1999 | A |
5888370 | Becker et al. | Mar 1999 | A |
5993630 | Becker et al. | Nov 1999 | A |
5993632 | Becker et al. | Nov 1999 | A |
6030401 | Marino | Feb 2000 | A |
6093205 | McLeod et al. | Jul 2000 | A |
6181961 | Prass | Jan 2001 | B1 |
6183518 | Ross et al. | Feb 2001 | B1 |
6206921 | Guagliano et al. | Mar 2001 | B1 |
6221082 | Marino et al. | Apr 2001 | B1 |
6224603 | Marino | May 2001 | B1 |
6251140 | Marino et al. | Jun 2001 | B1 |
6264659 | Ross et al. | Jul 2001 | B1 |
6266394 | Marino | Jul 2001 | B1 |
6266558 | Gozani et al. | Jul 2001 | B1 |
6280447 | Marino et al. | Aug 2001 | B1 |
6287832 | Becker et al. | Sep 2001 | B1 |
6290724 | Marino | Sep 2001 | B1 |
6312443 | Stone | Nov 2001 | B1 |
6324432 | Rigaux et al. | Nov 2001 | B1 |
6361508 | Johnson et al. | Mar 2002 | B1 |
6368325 | McKinley et al. | Apr 2002 | B1 |
6387070 | Marino et al. | May 2002 | B1 |
6387130 | Stone et al. | May 2002 | B1 |
6436143 | Ross et al. | Aug 2002 | B1 |
6466817 | Kaula et al. | Oct 2002 | B1 |
6478805 | Marino et al. | Nov 2002 | B1 |
6485518 | Cornwall et al. | Nov 2002 | B1 |
6491626 | Stone et al. | Dec 2002 | B1 |
6500128 | Marino | Dec 2002 | B2 |
6519319 | Marino et al. | Feb 2003 | B1 |
6530930 | Marino et al. | Mar 2003 | B1 |
6533797 | Stone et al. | Mar 2003 | B1 |
6540747 | Marino | Apr 2003 | B1 |
6564078 | Marino et al. | May 2003 | B1 |
6613007 | Reid, Jr. | Sep 2003 | B1 |
6638281 | Gorek | Oct 2003 | B2 |
6641708 | Becker et al. | Nov 2003 | B1 |
6654634 | Prass | Nov 2003 | B1 |
6739112 | Marino | May 2004 | B1 |
6760616 | Hoey et al. | Jul 2004 | B2 |
6764452 | Gillespie et al. | Jul 2004 | B1 |
6764489 | Ferree | Jul 2004 | B2 |
6802844 | Ferree | Oct 2004 | B2 |
6805668 | Cadwell | Oct 2004 | B1 |
6807438 | Brun Del Re et al. | Oct 2004 | B1 |
6843790 | Ferree | Jan 2005 | B2 |
6852126 | Ahlgren | Feb 2005 | B2 |
6870109 | Villarreal | Mar 2005 | B1 |
6887248 | McKinley et al. | May 2005 | B2 |
6923814 | Hildebrand et al. | Aug 2005 | B1 |
6945973 | Bray | Sep 2005 | B2 |
6964674 | Matsuura et al. | Nov 2005 | B1 |
6972199 | Lebouitz et al. | Dec 2005 | B2 |
6981990 | Keller | Jan 2006 | B2 |
7001432 | Keller et al. | Feb 2006 | B2 |
7025769 | Ferree | Apr 2006 | B1 |
7050848 | Hoey et al. | May 2006 | B2 |
7072521 | Cadwell | Jul 2006 | B1 |
7079883 | Marino et al. | Jul 2006 | B2 |
7160303 | Keller | Jan 2007 | B2 |
7162850 | Marino et al. | Jan 2007 | B2 |
7166113 | Arambula et al. | Jan 2007 | B2 |
7175662 | Link et al. | Feb 2007 | B2 |
7177677 | Kaula et al. | Feb 2007 | B2 |
7207949 | Miles et al. | Apr 2007 | B2 |
7214197 | Prass | May 2007 | B2 |
7214225 | Ellis et al. | May 2007 | B2 |
7216001 | Hacker et al. | May 2007 | B2 |
7230688 | Villarreal | Jun 2007 | B1 |
7236832 | Hemmerling et al. | Jun 2007 | B2 |
7267691 | Keller et al. | Sep 2007 | B2 |
7296500 | Martinelli | Nov 2007 | B1 |
7320689 | Keller | Jan 2008 | B2 |
7338531 | Ellis et al. | Mar 2008 | B2 |
7341590 | Ferree | Mar 2008 | B2 |
7367958 | McBean et al. | May 2008 | B2 |
7374448 | Jepsen et al. | May 2008 | B2 |
7379767 | Rea | May 2008 | B2 |
7470236 | Kelleher et al. | Dec 2008 | B1 |
7485146 | Crook et al. | Feb 2009 | B1 |
7522953 | Kaula et al. | Apr 2009 | B2 |
7527629 | Link et al. | May 2009 | B2 |
7527649 | Blain | May 2009 | B1 |
7553307 | Bleich et al. | Jun 2009 | B2 |
7555343 | Bleich | Jun 2009 | B2 |
7569067 | Keller | Aug 2009 | B2 |
7578819 | Bleich et al. | Aug 2009 | B2 |
7582058 | Miles et al. | Sep 2009 | B1 |
7583991 | Rea | Sep 2009 | B2 |
7611522 | Gorek | Nov 2009 | B2 |
7618423 | Valentine et al. | Nov 2009 | B1 |
7628813 | Link | Dec 2009 | B2 |
7634315 | Cholette | Dec 2009 | B2 |
7657308 | Miles et al. | Feb 2010 | B2 |
7664544 | Miles et al. | Feb 2010 | B2 |
7666195 | Kelleher et al. | Feb 2010 | B2 |
7668588 | Kovacs | Feb 2010 | B2 |
7691057 | Miles et al. | Apr 2010 | B2 |
7693562 | Marino et al. | Apr 2010 | B2 |
7708776 | Blain et al. | May 2010 | B1 |
7713463 | Reah et al. | May 2010 | B1 |
7722613 | Sutterlin et al. | May 2010 | B2 |
7722673 | Keller | May 2010 | B2 |
7738968 | Bleich | Jun 2010 | B2 |
7738969 | Bleich | Jun 2010 | B2 |
7740631 | Bleich et al. | Jun 2010 | B2 |
7766816 | Chin et al. | Aug 2010 | B2 |
7776049 | Curran et al. | Aug 2010 | B1 |
7776094 | McKinley et al. | Aug 2010 | B2 |
7785248 | Annest et al. | Aug 2010 | B2 |
7785253 | Arambula et al. | Aug 2010 | B1 |
7815682 | Peterson et al. | Oct 2010 | B1 |
7819801 | Miles et al. | Oct 2010 | B2 |
7828855 | Ellis et al. | Nov 2010 | B2 |
7833251 | Ahlgren et al. | Nov 2010 | B1 |
7857813 | Schmitz et al. | Dec 2010 | B2 |
7862592 | Peterson et al. | Jan 2011 | B2 |
7862614 | Keller et al. | Jan 2011 | B2 |
7867277 | Tohmeh | Jan 2011 | B1 |
7883527 | Matsuura et al. | Feb 2011 | B2 |
7887538 | Bleich et al. | Feb 2011 | B2 |
7887568 | Ahlgren | Feb 2011 | B2 |
7887595 | Pimenta | Feb 2011 | B1 |
7892173 | Miles et al. | Feb 2011 | B2 |
7901430 | Matsuura et al. | Mar 2011 | B2 |
7905840 | Pimenta et al. | Mar 2011 | B2 |
7905886 | Curran et al. | Mar 2011 | B1 |
7914350 | Bozich et al. | Mar 2011 | B1 |
7918849 | Bleich et al. | Apr 2011 | B2 |
7918891 | Curran et al. | Apr 2011 | B1 |
7920922 | Gharib et al. | Apr 2011 | B2 |
7927337 | Keller | Apr 2011 | B2 |
7935051 | Miles et al. | May 2011 | B2 |
7938830 | Saadat et al. | May 2011 | B2 |
7942104 | Butcher et al. | May 2011 | B2 |
7942826 | Scholl et al. | May 2011 | B1 |
7946236 | Butcher | May 2011 | B2 |
7959577 | Schmitz et al. | Jun 2011 | B2 |
7962191 | Marino et al. | Jun 2011 | B2 |
7963915 | Bleich | Jun 2011 | B2 |
7963927 | Kelleher et al. | Jun 2011 | B2 |
7981058 | Akay | Jul 2011 | B2 |
7981144 | Geist et al. | Jul 2011 | B2 |
7991463 | Kelleher et al. | Aug 2011 | B2 |
8000782 | Gharib et al. | Aug 2011 | B2 |
8005535 | Gharib et al. | Aug 2011 | B2 |
8012212 | Link et al. | Sep 2011 | B2 |
8016767 | Miles et al. | Sep 2011 | B2 |
8016776 | Bourget et al. | Sep 2011 | B2 |
8027716 | Gharib et al. | Sep 2011 | B2 |
8048080 | Bleich et al. | Nov 2011 | B2 |
8050769 | Gharib et al. | Nov 2011 | B2 |
8055349 | Gharib et al. | Nov 2011 | B2 |
8062298 | Schmitz et al. | Nov 2011 | B2 |
8062300 | Schmitz et al. | Nov 2011 | B2 |
8062369 | Link | Nov 2011 | B2 |
8062370 | Keller et al. | Nov 2011 | B2 |
8063770 | Costantino | Nov 2011 | B2 |
8068912 | Kaula et al. | Nov 2011 | B2 |
8070812 | Keller | Dec 2011 | B2 |
8074591 | Butcher et al. | Dec 2011 | B2 |
8075499 | Nathan et al. | Dec 2011 | B2 |
8075601 | Young | Dec 2011 | B2 |
8083685 | Fagin et al. | Dec 2011 | B2 |
8083796 | Raiszadeh et al. | Dec 2011 | B1 |
8088163 | Kleiner | Jan 2012 | B1 |
8088164 | Keller | Jan 2012 | B2 |
8090436 | Hoey et al. | Jan 2012 | B2 |
8092455 | Neubardt et al. | Jan 2012 | B2 |
8092456 | Bleich et al. | Jan 2012 | B2 |
8103339 | Rea | Jan 2012 | B2 |
8114019 | Miles et al. | Feb 2012 | B2 |
8114162 | Bradley | Feb 2012 | B1 |
8123668 | Annest et al. | Feb 2012 | B2 |
8133173 | Miles et al. | Mar 2012 | B2 |
8137284 | Miles et al. | Mar 2012 | B2 |
8147421 | Farquhar et al. | Apr 2012 | B2 |
8147551 | Link et al. | Apr 2012 | B2 |
8165653 | Marino et al. | Apr 2012 | B2 |
8167915 | Ferree et al. | May 2012 | B2 |
8172750 | Miles et al. | May 2012 | B2 |
8206312 | Farquhar | Jun 2012 | B2 |
8255044 | Miles et al. | Aug 2012 | B2 |
8255045 | Gharib et al. | Aug 2012 | B2 |
8303515 | Miles et al. | Nov 2012 | B2 |
8337410 | Kelleher et al. | Dec 2012 | B2 |
8343065 | Bartol et al. | Jan 2013 | B2 |
8343079 | Bartol et al. | Jan 2013 | B2 |
8394129 | Morgenstern Lopez et al. | Mar 2013 | B2 |
8500653 | Farquhar | Aug 2013 | B2 |
8500738 | Wolf, II | Aug 2013 | B2 |
8517954 | Bartol et al. | Aug 2013 | B2 |
8535224 | Cusimano Reaston et al. | Sep 2013 | B2 |
8538539 | Gharib et al. | Sep 2013 | B2 |
8556808 | Miles et al. | Oct 2013 | B2 |
8562539 | Marino | Oct 2013 | B2 |
8562660 | Peyman | Oct 2013 | B2 |
8568317 | Gharib et al. | Oct 2013 | B1 |
8591431 | Calancie et al. | Nov 2013 | B2 |
8641638 | Kelleher et al. | Feb 2014 | B2 |
8731654 | Johnson et al. | May 2014 | B2 |
8784330 | Scholl et al. | Jul 2014 | B1 |
8792977 | Kakei et al. | Jul 2014 | B2 |
8855822 | Bartol et al. | Oct 2014 | B2 |
8864654 | Kleiner et al. | Oct 2014 | B2 |
8936626 | Tohmeh et al. | Jan 2015 | B1 |
8945004 | Miles et al. | Feb 2015 | B2 |
8958869 | Kelleher et al. | Feb 2015 | B2 |
8982593 | Nondahl et al. | Mar 2015 | B2 |
8989855 | Murphy et al. | Mar 2015 | B2 |
8989866 | Gharib et al. | Mar 2015 | B2 |
9014776 | Marino et al. | Apr 2015 | B2 |
9014797 | Shiffman et al. | Apr 2015 | B2 |
9037250 | Kaula et al. | May 2015 | B2 |
9066701 | Finley et al. | Jun 2015 | B1 |
9084550 | Bartol | Jul 2015 | B1 |
9084551 | Brunnett et al. | Jul 2015 | B2 |
9131947 | Ferree | Sep 2015 | B2 |
9192415 | Arnold et al. | Nov 2015 | B1 |
9295396 | Gharib et al. | Mar 2016 | B2 |
9295401 | Cadwell | Mar 2016 | B2 |
9301711 | Bartol et al. | Apr 2016 | B2 |
9392953 | Gharib | Jul 2016 | B1 |
9446259 | Phillips et al. | Sep 2016 | B2 |
9622684 | Wybo et al. | Apr 2017 | B2 |
11510603 | Snow et al. | Nov 2022 | B2 |
20010031916 | Bennett et al. | Oct 2001 | A1 |
20020038092 | Stanaland et al. | Mar 2002 | A1 |
20020165590 | Crowe et al. | Nov 2002 | A1 |
20030074037 | Moore et al. | Apr 2003 | A1 |
20040077969 | Onda et al. | Apr 2004 | A1 |
20040082877 | Kouou et al. | Apr 2004 | A1 |
20040186535 | Knowlton | Sep 2004 | A1 |
20040230138 | Inoue et al. | Nov 2004 | A1 |
20040243018 | Organ et al. | Dec 2004 | A1 |
20050075578 | Gharib et al. | Apr 2005 | A1 |
20050085741 | Hoskonen et al. | Apr 2005 | A1 |
20050102007 | Ayal et al. | May 2005 | A1 |
20050240086 | Akay | Oct 2005 | A1 |
20050245839 | Stivoric et al. | Nov 2005 | A1 |
20050280531 | Fadem et al. | Dec 2005 | A1 |
20050283204 | Buhlmann et al. | Dec 2005 | A1 |
20060020177 | Seo et al. | Jan 2006 | A1 |
20060052726 | Weisz et al. | Mar 2006 | A1 |
20060135888 | Mimnagh-Kelleher et al. | Jun 2006 | A1 |
20060270949 | Mathie et al. | Nov 2006 | A1 |
20060276704 | McGinnis et al. | Dec 2006 | A1 |
20070038155 | Kelly, Jr. et al. | Feb 2007 | A1 |
20070049826 | Willis | Mar 2007 | A1 |
20070232958 | Donofrio et al. | Oct 2007 | A1 |
20070265675 | Lund et al. | Nov 2007 | A1 |
20070276270 | Tran | Nov 2007 | A1 |
20080051643 | Park et al. | Feb 2008 | A1 |
20080058656 | Costello et al. | Mar 2008 | A1 |
20080167695 | Tehrani et al. | Jul 2008 | A1 |
20080234767 | Salmon et al. | Sep 2008 | A1 |
20080306363 | Chaiken et al. | Dec 2008 | A1 |
20080306397 | Bonmassar et al. | Dec 2008 | A1 |
20080312560 | Jamsen et al. | Dec 2008 | A1 |
20080312709 | Volpe et al. | Dec 2008 | A1 |
20090036747 | Hayter et al. | Feb 2009 | A1 |
20090062696 | Nathan et al. | Mar 2009 | A1 |
20090069709 | Schmitz et al. | Mar 2009 | A1 |
20090069722 | Flaction et al. | Mar 2009 | A1 |
20090076336 | Mazar et al. | Mar 2009 | A1 |
20090171381 | Schmitz et al. | Jul 2009 | A1 |
20090192413 | Sela et al. | Jul 2009 | A1 |
20090228068 | Buhlmann et al. | Sep 2009 | A1 |
20090247910 | Klapper | Oct 2009 | A1 |
20090299239 | Meyer | Dec 2009 | A1 |
20090306741 | Hogle et al. | Dec 2009 | A1 |
20090318779 | Tran | Dec 2009 | A1 |
20100137748 | Sone et al. | Jun 2010 | A1 |
20100152619 | Kalpaxis et al. | Jun 2010 | A1 |
20100152622 | Teulings | Jun 2010 | A1 |
20100152623 | Williams | Jun 2010 | A1 |
20100168559 | Tegg et al. | Jul 2010 | A1 |
20100262042 | Kim | Oct 2010 | A1 |
20100292617 | Lei et al. | Nov 2010 | A1 |
20110004207 | Wallace et al. | Jan 2011 | A1 |
20110230782 | Bartol et al. | Sep 2011 | A1 |
20110237974 | Bartol et al. | Sep 2011 | A1 |
20110270121 | Johnson et al. | Nov 2011 | A1 |
20110301665 | Mercanzini et al. | Dec 2011 | A1 |
20120053491 | Nathan et al. | Mar 2012 | A1 |
20120191003 | Garabedian et al. | Jul 2012 | A1 |
20130197321 | Wilson | Aug 2013 | A1 |
20130204097 | Rondoni et al. | Aug 2013 | A1 |
20130213659 | Luyster et al. | Aug 2013 | A1 |
20130253334 | Al-Ali | Sep 2013 | A1 |
20130253533 | Bartol et al. | Sep 2013 | A1 |
20140020178 | Stashuk et al. | Jan 2014 | A1 |
20140066803 | Choi | Mar 2014 | A1 |
20140088029 | Sugimoto et al. | Mar 2014 | A1 |
20140107524 | Brull | Apr 2014 | A1 |
20140121555 | Scott et al. | May 2014 | A1 |
20140148725 | Cadwell | May 2014 | A1 |
20140163411 | Rea | Jun 2014 | A1 |
20140275926 | Scott et al. | Sep 2014 | A1 |
20140276195 | Papay et al. | Sep 2014 | A1 |
20140336722 | Rocon De Lima | Nov 2014 | A1 |
20140358026 | Mashiach et al. | Dec 2014 | A1 |
20150032022 | Stone | Jan 2015 | A1 |
20150045783 | Edidin | Feb 2015 | A1 |
20150051506 | Wybo et al. | Feb 2015 | A1 |
20150112325 | Whitman | Apr 2015 | A1 |
20150230749 | Gharib et al. | Aug 2015 | A1 |
20150342521 | Narita et al. | Dec 2015 | A1 |
20150342621 | Jackson, III | Dec 2015 | A1 |
20160051812 | Montgomery, Jr. et al. | Feb 2016 | A1 |
20170361093 | Yoo | Dec 2017 | A1 |
20180132757 | Kong et al. | May 2018 | A1 |
20190223764 | Hulvershorn et al. | Jul 2019 | A1 |
Number | Date | Country |
---|---|---|
101822870 | Sep 2010 | CN |
105786155 | Jul 2016 | CN |
106097787 | Nov 2016 | CN |
106999081 | Aug 2017 | CN |
107041748 | Aug 2017 | CN |
1417000 | May 2004 | EP |
1575010 | Sep 2005 | EP |
2231003 | Sep 2010 | EP |
2535082 | Dec 2012 | EP |
2920087 | Feb 2009 | FR |
2003-503105 | Jan 2003 | JP |
2003-514607 | Apr 2003 | JP |
2005-349021 | Dec 2005 | JP |
2017-217443 | Dec 2017 | JP |
0078209 | Dec 2000 | WO |
2007024147 | Mar 2007 | WO |
2014160832 | Oct 2014 | WO |
2015171619 | Nov 2015 | WO |
2016100340 | Jun 2016 | WO |
2018065971 | Apr 2018 | WO |
Entry |
---|
J. Herdmann MD; V. Deletis MD PHD; H.Edmonds PHD; N. Morota MD, Spinal Cord and Nerve Root Monitoring in Spine Surgery and Related Procedures, Spine Journal, Apr. 1, 1996, pp. 879-885, vol. 21. |
N. Hollands MB, BS; J. Kostuik. Continuous Electromyographic Moniotring to Detect Nerve Root Injury During Thoracolumbar Scoliosis Surgery, Spine Journal, Nov. 1, 1997, pp. 2547-2550, vol. 22, Issue 21. |
C. Harper, J. Daube, Facial Nerve Electromyography and Other Cranial Nerve Monitoring, Journal of Clinical Neurophysiology, May 1998, pp. 206-216, vol. 15, Issue 3. |
D. Beck, J. Ben Ecke Jr, Intraoperative Facial Nerve Monitoring Technical Aspects, Official Journal of the American Academy of Otolaryngology—Head and Neck Surgery Foundation, Apr. 27, 1989. |
W. Welch MD, R. Rose PHD, J. Balzer PHD, G. Jacobs, MD, Evaluation with evoked and spontaneous electromyography during lumbar instrumentation: a prospective study, Journal of Neurosurgery, Sep. 1997, pp. 397-402, vol. 87, No. 3. |
W. Young MD, D. Morledge PHD, W. Martin PHD, K. Park MD, Intraoperative Stimulation of Pedicle Screws: A New Method for Verification of Screw Placement, Journal of Neurosurgery, 1995, pp. 544-547 vol. 44. |
K. Sugita MD, S. Kobayashi MD, Technical and instrumental improvements in the surgical treatment of acoustic neurinomas, Journal of Neurosurgery, Dec. 1982, pp. 747-752, vol. 57. |
J. Boston, L. Deneault, Sensory evoked potentials: a system for clinical testing and patient monitoring, International Journal of Clinical Monitoring and Computing, 1984, pp. 13-19, Martinus Nijhoff Publishers, Netherlands. |
A. Moller, Neuromonitoring in Operations in the Skull Base, The Keio Journal of Medicine, Oct. 1991, pp. 151-159. |
J. Maurer, H. Pelster, W. Mann, Intraoperatives Monitoring motorischer Humnerven bei Operationen an Hals und Schadelbasis, Laryngo-Rhino-Otol, pp. 561-567, vol. 73. |
W. Friedman MD, M. Curran R. EPT, Somatosensory Evoked Potentials after Sequential Extremity Stimulation: A New Method for Improved Monitoring Accuracy, Neurosurgery, 1987, pp. 755-758, vol. 21, No. 5. |
R. Gopalan, P. Parker, R. Scott, Microprocessor-Based System for Monitoring Spinal Evoked Potentials During Surgery, IEEE Transactions on Biomedical Engineering, Oct. 1986, pp. 982-985, vol. BME-22, No. 10. |
B. Moed MD, B. Ahmad MD, J. Craig MD, G. Jacobson PHD, M. Anders MD, Intraoperative Monitoring with Stimulus-Evoked Electromyography during Placement lliosacral Screws, The Journal of Bone and Joint Surgery, Apr. 1998, pp. 537-546, vol. 80-A, No. 4, The Journal of Bone and Joint Surgery, Inc. |
C. Yingling PHD, J. Gardi PHD, Intraoperative Monitoring of Facial and Cochlear Nerves During Acoustic Neuroma Surgery, Acoustic Neuroma I, Apr. 1992, pp. 413-448, vol. 25, No. 2, Otolaryngologic Clinics of North America. |
N. Holland MB, BS, J. Kostuik MD, Continuous Electromyographic Monitoring to Detect Nerve Root Injury During Thoracolumbar Scoliosis Surgery, Spine, 1997, pp. 2547-2550, vol. 22, No. 21, Lippincott-Raven Publishers. |
P. Dulguerov, F. Marchal, W. Lehmann, Postparotidectomy Facial Nerve Paralysis: Possible Etiologic Factors and Results with Routine Facial Nerve Monitoring, The Laryngoscope, May 1999, pp. 754-762 vol. 109, Lippincott Williams & Wilkins, Inc. Philadelphia, Pennsylvania. |
M. Imai MS, Y. Harada MD, Y. Atsuta MD, Y. Takemitsu MD, T. Iwahara MD, Automated Spinal Cord Monitoring for Spinal Surgery, Paraplegia, 1989, pp. 204-211. |
R. Witt, Facial nerve monitoring in parotid surgery: The standard of care?, Otolaryngology-Head and Neck Surgery, Nov. 1998, pp. 468-470, vol. 119, No. 5. |
Bartol, Stephen MD, and Laschuk, Maria MD, “Arthroscopic Microscopic Discectomy in Awake Patients: The Effectiveness of Local/Neurolept Anaesthetic”, Canadian Spine Society Meeting, Vernon, BC, Canada, Mar. 2002. |
Bartol, Stephen MD, and Laschuk, Maria MD, “Use of Nerve Stimulator to Localize the Spinal Nerve Root During Arthroscopic Discectomy Procedures”, Canadian Spine Society Meeting, Vernon, BC, Canada, Mar. 2002. |
Begg et al. “Computational Intelligence for Movement Sciences: Neural Networks and Other Emerging Techniques” 2006. |
Bourke et al. “A Threshold-Based Fall-Detection Algorithm Using a Bi-Axial Gyroscope Sensor” Medical Engineering and Physics 30 (2008) 84-90. |
Fee Jr., James W.; Miller, Freeman; Lennon, Nancy; “EMG Reaction in Muscles About the Knee to Passive Velocity, Acceleration, and Jerk Manipulations”; Alfred I. duPont Hospital for Children, Gait Laboratory, 1600 Rockland Road, Wilmington, DE 19899, United States Journal of Electromyography and Kinesiology 19 (2009) 467-475. |
Koceja, D.M., Bernacki, R.H. and Kamen, G., “Methodology for the Quantitative Assessment of Human Crossed-Spinal Reflex Pathways,” Medical & Biological Engineering & Computing, Nov. 1991, pp. 603-606, No. 6, US. |
Tarata, M.; Spaepen, A.; Puers, R.; “The Accelerometer MMG Measurement Approach, in Monitoring the Muscular Fatigue”; Measurement Science Review; 2001; vol. 1, No. 1. |
Murphy, Chris; Campbell, Niall; Caulfield, Brian; Ward, Tomas and Deegan, Catherine; “Micro Electro Mechanical Systems Based Sensor for Mechanomyography”, 19th international conference BIOSIGNAL 2008, Brno, Czech Republic. |
Nijsen, Tamara M.E.; Aarts, Ronald M.; Arends, Johan B.A.M.; Cluitmans, Pierre J.M.; “Model for Arm Movements During Myoclonic Seizures”; Proceedings of the 29th Annual International Conference of the IEEE EMBS Cite Internationale, Lyon, France Aug. 23-26, 2007. |
Ohta, Yoichi; Shima, Norihiro; Yabe, Kyonosuke; “Superimposed Mechanomyographic Response at Different Contraction Intensity in Medial Gastrocnemius and Soleus Muscles”; International Journal of Sport and Health Science, vol. 5, 63-70, 2007. |
Navid, Amini, et al., “Accelerometer-based on-body sensor localization for health and medical monitoring applications”, Pervasive and Mobile Computing, vol. 7, No. 6, Sep. 21, 2011, 15 pages. |
CN 101822870 (A) Cited in Office action dated Jan. 9, 2024, in related Chinese application No. 201910962352.8. |
CN 105786155 (A) Cited in Office action dated Jan. 9, 2024, in related Chinese application No. 201910962352.8. |
CN 106097787 (A) Cited in Office action dated Jan. 9, 2024, in related Chinese application No. 201910962352.8. |
CN 107041748 (A) Cited in Office action dated Jan. 9, 2024, in related Chinese application No. 201910962352.8. |
CN 106999081 (A) U.S. Pat. No. 11,510,603 (B2). |
Number | Date | Country | |
---|---|---|---|
20210060337 A1 | Mar 2021 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16158734 | Oct 2018 | US |
Child | 17096947 | US |